卫光生物(002880.SZ)：子公司拟参与设立投资基金

Core Viewpoint - Weigao Bio (002880.SZ) announced the establishment of a new private equity investment fund named Shenzhen Guangming Qihang New Journey Private Equity Investment Fund Partnership (Limited Partnership), with a total scale of RMB 55 million [1] Group 1: Investment Details - Weigao Investment, a wholly-owned subsidiary of Weigao Bio, will contribute RMB 16.5 million, holding a 30% share in the partnership [1] - The fund will primarily invest in strategic emerging industries supported by the Guangming District government, including biomedicine, synthetic biology, medical devices, and brain science [1] Group 2: Partnership Composition - The fund is established in collaboration with Shenzhen Kefa Capital Private Equity Fund Management Co., Shenzhen Weigao Venture Capital Co., and Shenzhen Guangming District Guidance Fund Investment Management Co. [1]